A. PURPOSE OF THE CORE AND SPECIFIC AIMS The goals of the CAPS Policy and Ethics Core are to assure that HIV research at CAPS meets the highest ethical standards, addresses important policy questions, and has a high impact on the policy making process. The core provides consultation to HIV scientists on how to resolve the ethical dilemmas that inevitably arise in HIV prevention and treatment research and on how to increase the policy impact of their research. Moreover, the core supports research on emerging policies such as routine testing and pre-exposure prophylaxis. Over the next project period, we will focus on addressing critical ethics and policy issues associated with our long-term goals?supporting research to reduce the number of new infections, improve health outcomes among HIV-infected individuals, and reduce HIV-related health disparities. This will include a focus on improving the implementation of evidence-based approaches to prevention and treatment and on evaluating the impact of policy changes, including changes to the HIV prevention and treatment landscape resulting from health care reform and development of the National HIV/AIDS Strategy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH062246-13
Application #
8536380
Study Section
Special Emphasis Panel (ZMH1-ERB-M)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
13
Fiscal Year
2013
Total Cost
$196,856
Indirect Cost
$37,184
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Rebeiro, Peter F; Gange, Stephen J; Horberg, Michael A et al. (2016) Geographic Variations in Retention in Care among HIV-Infected Adults in the United States. PLoS One 11:e0146119
Cesar, Carina; Koethe, John R; Giganti, Mark J et al. (2016) Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America. J Int AIDS Soc 19:20684
Rachlis, Beth; Karwa, Rakhi; Chema, Celia et al. (2016) Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Saf 39:959-76
Buchacz, Kate; Lau, Bryan; Jing, Yuezhou et al. (2016) Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. J Infect Dis 214:862-72
Klein, Marina B; Althoff, Keri N; Jing, Yuezhou et al. (2016) Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clin Infect Dis 63:1160-1167
Koethe, John R; Jenkins, Cathy A; Lau, Bryan et al. (2016) Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr 73:197-204
Sauceda, John A; Wiebe, John S; Simoni, Jane M (2016) Childhood sexual abuse and depression in Latino men who have sex with men: Does resilience protect against nonadherence to antiretroviral therapy? J Health Psychol 21:1096-106
Vincent, Wilson; Gordon, Derrick M; Campbell, Christina et al. (2016) Adherence to Traditionally Masculine Norms and Condom-Related Beliefs: Emphasis on African American and Hispanic Men. Psychol Men Masc 17:42-53
Pettit, April C; Mendes, Adell; Jenkins, Cathy et al. (2016) Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment. J Acquir Immune Defic Syndr 72:572-8
Conroy, Amy A; McGrath, Nuala; van Rooyen, Heidi et al. (2016) Power and the association with relationship quality in South African couples: Implications for HIV/AIDS interventions. Soc Sci Med 153:1-11

Showing the most recent 10 out of 432 publications